Characterization of Cancer-Related Binding Domains with the ProteOn™ XPR36 Biosensor





The interactive transcript could not be loaded.


Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Sep 14, 2012

For more info, visit http://www.bio-rad.com/yt/2/proteonxpr36
A prominent challenge to overcome in the field of combinatorial protein engineering is functional screening of identified candidate molecules. The ability to achieve a full kinetic characterization during screening yields valuable insights. In this webinar, the presenters present their experience and methodology in characterizing bispecific affinity molecules. The binding molecules are derived from a combinatorial protein library based on a single albumin-binding domain selected to specifically bind a cancer-related receptor protein. In addition, a demanding competition assay is presented where selected binding proteins compete with the extracellular domain of the receptor for binding to an immobilized natural ligand.


We Are Bio-Rad.

Our mission: To provide useful, high-quality products and services that advance scientific discovery and improve healthcare. At Bio-Rad, we are united behind this effort. These two objectives are the driving force behind every decision we make, from developing innovative ideas to building global solutions that help solve our customers' greatest challenges.

Connect with Bio-Rad Online:
Website: http://www.bio-rad.com/
LinkedIn: https://www.linkedin.com/company/1613...
Facebook: https://www.facebook.com/biorad/
Twitter: https://twitter.com/BioRadLifeSci
Instagram: @BioRadLabs
Snapchat: @BioRadLabs


When autoplay is enabled, a suggested video will automatically play next.

Up next

to add this to Watch Later

Add to

Loading playlists...